Free Trial

vTv Therapeutics (VTVT) SEC Filings & 10K Form

vTv Therapeutics logo
$19.96 -0.03 (-0.15%)
As of 09:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent vTv Therapeutics SEC Filings

DateFilerForm TypeView
05/21/2025
5:16 PM
Tung Michael Stephen (Reporting)
vTv Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2025
5:17 PM
Tung Michael Stephen (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
3:24 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
8:05 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:07 PM
vTv Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
3:28 PM
Tuch Steven L. (Reporting)
vTv Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2025
3:40 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:27 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
3:28 PM
vTv Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2025
8:03 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:14 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:33 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:15 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:15 PM
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:40 AM
FMR LLC (Filed by)
vTv Therapeutics (Subject)
Form SC 13G
10/25/2024
3:29 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:28 PM
vTv Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:27 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:17 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:41 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:39 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:40 PM
SPIEGELMAN DANIEL K (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:37 PM
Phillips Anne M. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:38 PM
Al-Marzooqi Fahed (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:22 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:37 PM
Phillips Anne M. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:38 PM
Tuch Steven L. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:40 PM
SEKHRI PAUL J (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:42 PM
Al-Marzooqi Fahed (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VTVT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners